CAS: 70458-92-3 Pefloxacin Antibiotic Powder

Min.Order: 1

Product origin: Xi'an, Shaanxi, China

Infringement complaint:

Complaint

US$ 70 ~ 100

Description

Cas:70458-92-3 Pefloxacin Antibiotic powder

product name	Pefloxacin
cas number	70458-92-3
apperance	white powder
Density	1.3±0.1 g/cm3
MF	C₁₇H₂₀FN₃O₃
MW	333.357

English name: 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
English alias: Silver Pefloxacin; Pefloxacinum; PFLX; Abactal; Pefloxacine
CAS Number: 70458-92-3
Molecular formula: C17H20FN3O3
Molecular weight: 333.35700
Accurate quality: 333.14900
PSA: 65.78000
LogP: 1.61340
Physical and chemical properties
Density: 1.32 g/cm3
Boiling point: 529.1ºC at 760 mmHg
Flash point: 273.8ºC
Refractive index: 1.593
Vapor pressure: 5.05E-12mmHg at 25°C [1]
Security Information
Dangerous goods transport code: UN 3082
Hazard category code: R51/53
Safety instructions: S61
RTECS number: WM6250000
Dangerous goods mark: N
Molecular structure data
1. Molar refractive index: 85.63
2. Molar volume (cm/mol): 252.4
3. Isotonic specific volume (90.2K): 679.3
4. Surface tension (dyne/cm): 52.4
5. Polarizability (10-24cm3): 33.94
Computational chemistry data
1. Hydrophobic parameter calculation reference value (XlogP): none
2. Number of hydrogen bond donors: 1
3. Number of hydrogen bond acceptors: 7
4. Number of rotatable chemical bonds: 3
5. Number of tautomers: none
6. Polar surface area of topological molecules 64.1
7. Number of heavy atoms: 24
8. Surface charge: 0
9. Complexity: 545
10. Number of isotope atoms: 0
11. Determine the number of atomic stereo centers: 0
12. Uncertain the number of atomic stereocenters: 0
13. Determine the number of chemical bond stereo centers: 0
14. Uncertain the number of chemical bond stereo centers: 0
15. Number of covalent bond units: 1

See Norfloxacin for clinical indications. Intravenous administration can still be used for severe cases of pulmonary infection, and it can also be used for gram-negative bacilli sepsis. The treatment of sepsis often needs to be combined with antibacterial drugs that have a synergistic effect. Used for serious infections of G-bacteria and Staphylococcus in adults such as sepsis, endocarditis, bacterial meningitis, infections of the respiratory tract, urethra, kidney, ENT, gynecological diseases, abdomen, liver and gallbladder, osteoarthritis and skin infections, etc.

Forward

Related products